The introduction of the vacuum tube in 1949 revolutionized blood collection, significantly
improving sample quality and patient comfort. Over the past 75 years, laboratory diagnostics …

Breast cancer (BC) is one of the most heterogeneous groups of cancer. As every biotype of
BC is unique and presents a particular “omic” signature, they are increasingly characterized …

Transforming growth factor-β superfamily members, such as myostatin, growth/differentiation
factor 11, and activin A, negatively regulate skeletal muscle mass. Inhibitors targeting these …

Therapeutic drug monitoring (TDM) may be beneficial for cyclin-dependent kinase 4/6
inhibitors (CDK4/6is), such as palbociclib, ribociclib, and abemaciclib, due to established …

Blood microsampling (BµS) offers an alternative to conventional methods that use plasma or
serum for profiling human health, being minimally invasive and cost effective, especially …

Olaparib is a small-molecule inhibitor of poly (ADP)-ribose polymerase (PARP) used as
maintenance therapy for recurrent ovarian cancer and newly diagnosed advanced ovarian …

Olaparib, an oral poly-ADP ribose polymerase (PARP) inhibitor, is a relatively new
anticancer drug. It is essential to find TDM-guided dosage for better safety and tolerability …